Megafine Pharma Private Limited, a active private limited company, was established on 22 August 1995 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239MH1995PTC092028. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.53 Cr.
It upholds a compliant status. Employing 758 professional, Its leadership includes Rohit Brijmohan Mantri (Nominee Director), Shailesh Jethmal Sanghvi (Managing Director), Hari Prasshanth (Nominee Director). Past directors included Ashok Kirtilal Jhaveri, Rohit Brijmohan Mantri, Hasmukh Purushottam Gandhi. It holds ₹48.00 Cr open charges and ₹48.75 Cr settled loans. Its latest AGM occurred on 17 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sethna Building,4Th Floor, 55 Maharshi Karve Road, Marine Lines, Mumbai, Maharashtra, 400002.
U24239MH1995PTC092028
092028
22 August 1995
₹2.00 Cr
₹1.53 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Megafine Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rohit Brijmohan Mantri | Nominee Director | 21 Feb 2025 | Current |
| Shailesh Jethmal Sanghvi | Managing Director | 22 Aug 1995 | Current |
| Hari Prasshanth | Nominee Director | 06 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 24 Dec 2018 | Past |
| Pramod Abcsdd | Additional Director | 21 Feb 2025 | Past |
| Pramod Abcsdd | Director | 20 Aug 2014 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2019 | Past |
| Pramod Abcsdd | Director | 20 Aug 2014 | Past |
| Pramod Abcsdd | Additional Director | 03 Apr 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mega Fine Pharma Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 7% increase. The company also saw a slight decrease in profitability, with a 7.66% decrease in profit. The company's net worth Soared by an impressive increase of 15.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Megafine Pharma had a promoter holding of 49.24% and a public holding of 50.76%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹480,000,000.00
₹487,523,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Apr 2012 | Hdfc Bank Limited | ₹8.50 Cr | Open |
| 13 Jun 2006 | State Bank Of India | ₹39.50 Cr | Open |
| 22 Nov 2019 | Hdfc Bank Limited | ₹44.50 Cr | Satisfied |
| 29 Sep 2003 | Canara Bank | ₹2.70 Cr | Satisfied |
| 05 Jun 2002 | Canara Bank | ₹0.80 M | Satisfied |
Explore comprehensive loan charge details -
Megafine Pharma has a workforce of 758 employees as of Dec 12, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Megafine Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Megafine Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Megafine Pharma Private Limited last Annual general meeting of members was held on 17 Sep 2025 as per latest MCA records. was documented.
The activity Megafine Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
The activity Hari Prasshanth was appointed as a Nominee Director was appointed as a Nominee Director on 06 Mar 2025 & has been associated with this company since 8 months 25 days . was completed.
Progress on Rohit Brijmohan Mantri was appointed as a Nominee Director was appointed as a Nominee Director on 21 Feb 2025 & has been associated with this company since 9 months 8 days . was documented.
Progress on A charge registered on 22 Nov 2019 via Charge ID 100304683 with Hdfc Bank Limited was fully satisfied on 14 Aug 2024. was documented.
A charge with Hdfc Bank Limited of Rs. 8.50 Cr registered on 26 Apr 2012 with Charge ID 10350830 was modified on 01 Aug 2024. was recorded as a recent event.
USFDA to Megafine Pharma: "Your Vapi facility in Gujarat has major violations of good manufacturing norms. You used bad materials and didn't clean equipment properly. Your test methods can't prove drug purity. Your quality system is not reliable. Fix everything or we won't approve your new drugs. Keep this up and we won't let your drugs into the US..
The CIN of Megafine Pharma Private Limited is U24239MH1995PTC092028.
Megafine Pharma Private Limited is headquartered at Sethna Building,4Th Floor, 55 Maharshi Karve Road, Marine Lines, Mumbai, Maharashtra, 400002.
Megafine Pharma Private Limited was incorporated on 22 August 1995.
The current directors of Megafine Pharma Private Limited are
The primary industry of Megafine Pharma Private Limited is Manufacturing.
Megafine Pharma Private Limited is unlisted.
The authorized capital of Megafine Pharma Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.53 Cr.
The compliance status of Megafine Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX